← Twist Bioscience Corp
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | — | ($107.7m) | ($139.9m) | ($152.1m) | ($217.9m) | ($204.6m) | ($208.7m) | ($77.7m) | ($136.7m) | |
| Net loss | ($59.3m) | ($71.2m) | ($107.7m) | ($139.9m) | ($152.1m) | ($217.9m) | ($204.6m) | ($208.7m) | ($77.7m) | — | |
| Depreciation, Depletion and Amortization | — | — | $6.1m | $6.7m | $9.8m | $16.5m | $29.3m | $31.4m | $24.9m | $25.4m | |
| Depreciation | — | — | — | — | — | $16.5m | $29.3m | $27.3m | $23.8m | $25.4m | |
| Amortization of Intangible Assets | — | — | — | — | — | $4.9m | $5.3m | $4.1m | $1.1m | — | |
| Capitalized Computer Software, Amortization | — | — | — | — | — | — | — | $2.6m | $2.9m | — | |
| Depreciation and amortization expense | $5.0m | $5.7m | $6.1m | $6.7m | $9.8m | $16.5m | $29.3m | $31.4m | $24.9m | $25.4m | |
| Amortization Of Securities | — | — | — | — | $593k | $1.3m | — | — | — | — | |
| Depreciation Amortization Depletion | — | — | — | — | — | $16.5m | $29.3m | $31.4m | $24.9m | $25.4m | |
| Deferred Income Tax Expense (Benefit) | — | — | — | — | ($2.0m) | ($11.2m) | $0 | $0 | $0 | — | |
| Share-based Payment Arrangement, Noncash Expense | — | — | $11.2m | $17.1m | $37.0m | $79.7m | $30.3m | $50.9m | $64.5m | $66.5m | |
| Share-based Payment Arrangement, Expense | — | — | $11.2m | $17.1m | $37.0m | $79.0m | $30.3m | $50.9m | $64.5m | $66.5m | |
| Stock-based compensation expense | $1.9m | $3.0m | $11.2m | $17.1m | $37.0m | $79.7m | $30.3m | $50.9m | $64.5m | $66.5m | |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | — | — | — | — | — | $1.1m | — | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | $0 | $0 | — | $35.9m | $4.5m | — | |
| Operating Lease, Impairment Loss | — | — | — | ($1.0m) | $2.2m | $20.1m | $2.6m | $940k | ($20k) | — | |
| Impairment of long-lived assets | $507k | $55k | $189k | $0 | $2k | $0 | $6.8m | $44.9m | $0 | — | |
| Asset Impairment Charge | — | — | — | — | — | $0 | $6.8m | $44.9m | $0 | $0 | |
| Other Nonoperating Income (Expense) | — | — | ($265k) | ($182k) | ($1.4m) | ($1.1m) | ($667k) | ($2.6m) | ($903k) | — | |
| Changes in operating assets and liabilities: | |||||||||||
| Change In Working Capital | — | — | — | — | — | ($5.4m) | ($1.0m) | $15.4m | ($12.6m) | ($7.8m) | |
| Increase (Decrease) in Accounts Receivable | — | — | $6.7m | $14.3m | $2.2m | $9.6m | $4.3m | ($8.4m) | $22.4m | ($15.7m) | |
| Accounts receivable, net | ($1.6m) | ($3.1m) | ($6.7m) | ($14.3m) | ($2.2m) | ($9.6m) | ($4.3m) | $8.4m | ($22.4m) | ($15.7m) | |
| Change In Receivables | — | — | — | — | — | ($9.6m) | ($4.3m) | $8.4m | ($22.4m) | ($15.7m) | |
| Changes In Account Receivables | — | — | — | — | — | ($9.6m) | ($4.3m) | $8.4m | ($22.4m) | ($15.7m) | |
| Increase (Decrease) in Inventories | — | — | $1.3m | $5.0m | $19.5m | $7.5m | ($7.2m) | ($8.0m) | $4.2m | ($9.2m) | |
| Inventories | ($599k) | ($4.2m) | ($1.3m) | ($5.0m) | ($19.5m) | ($7.5m) | $7.2m | $8.0m | ($4.2m) | ($9.2m) | |
| Change In Inventory | — | — | — | — | — | ($7.5m) | $7.2m | $8.0m | ($4.2m) | ($9.2m) | |
| Increase (Decrease) in Accounts Payable | $560k | $3.8m | $3.3m | ($5.5m) | $8.5m | $7.4m | ($2.5m) | ($11.8m) | $9.3m | $4.3m | |
| Property and equipment additions included in accrued expenses and accounts payable | $285k | $344k | $170k | $1.3m | $2.0m | $6.3m | $772k | $92k | $2.4m | — | |
| Change In Payables And Accrued Expense | — | — | — | — | — | $14.5m | ($1.0m) | $485k | $12.7m | $4.3m | |
| Accrued expenses | $621k | ($114k) | $4.2m | ($2.6m) | $3.1m | $2.3m | $2.6m | $4.4m | $5.8m | $28.4m | |
| Accrued compensation | $1.1m | $1.9m | $5.1m | $4.5m | $7.4m | $4.9m | ($1.1m) | $7.9m | ($2.4m) | — | |
| Change In Accrued Expense | — | — | — | — | — | $7.1m | $1.5m | $12.3m | $3.3m | $28.4m | |
| Prepaid expenses and other current assets | ($324k) | ($1.8m) | $746k | ($3.7m) | ($2.1m) | ($2.6m) | ($4.2m) | $382k | ($3.7m) | — | |
| Other liabilities | $650k | $50k | ($247k) | $2.0m | ($28k) | ($7.4m) | ($108k) | ($2.3m) | $6.6m | — | |
| Change In Other Current Assets | — | — | — | — | — | $7.3m | $1.4m | $431k | ($1.6m) | ($1.3m) | |
| Change In Other Current Liabilities | — | — | — | — | — | ($7.4m) | ($108k) | ($2.3m) | $6.6m | $8.5m | |
| Net Cash Provided by (Used in) Operating Activities | ($51.3m) |
($66.2m)
-28.97%
|
($87.9m)
-32.91%
|
($142.3m)
-61.77%
|
($112.2m)
+21.10%
|
($124.4m)
-10.82%
|
($142.5m)
-14.54%
|
($64.1m)
+55.01%
|
($47.6m)
+25.69%
|
($53.1m)
-11.43%
|
|
| Cash flows from investing activities: | |||||||||||
| Gain (Loss) on Disposition of Property Plant Equipment | $266k | $17k | ($189k) | $0 | ($2k) | $0 | ($6.8m) | ($44.9m) | $0 | ($48.8m) | |
| Payments to Acquire Property, Plant, and Equipment | ($6.6m) | ($3.7m) | $14.8m | $9.9m | $27.1m | $101.9m | $27.8m | $5.1m | $28.0m | ($40.2m) | |
| Payments to Acquire Investments | — | — | $177.6m | $202.9m | $58.8m | $217.6m | $76.3m | $51.9m | $49.4m | ($59.6m) | |
| Purchases of investments | ($40.6m) | ($3.5m) | ($177.6m) | ($202.9m) | ($58.8m) | ($217.6m) | ($76.3m) | ($51.9m) | ($49.4m) | — | |
| Proceeds from maturity of investments | $36.9m | $34.5m | $87.5m | $98.1m | $242.5m | $100.5m | $154.7m | $53.9m | $50.1m | — | |
| Cash, Cash Equivalents, and Short-term Investments | — | — | $138.1m | $290.0m | $477.9m | $505.0m | $336.4m | — | — | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | $483k | $8.2m | $0 | $0 | — | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($10.0m) | $27.3m | ($104.8m) | ($114.7m) | $156.2m | ($232.9m) | $50.6m | ($3.1m) | ($24.8m) | ($45.2m) | |
| Cash flows from financing activities: | |||||||||||
| Net Issuance Payments Of Debt | — | — | — | — | ($3.3m) | ($1.6m) | $0 | $0 | — | $0 | |
| Net Long Term Debt Issuance | — | — | — | — | ($3.3m) | ($1.6m) | $0 | $0 | — | $0 | |
| Repayments of Long-term Debt | — | — | $2.5m | $3.3m | $3.3m | $1.6m | $0 | $0 | — | $0 | |
| Long Term Debt Payments | — | — | — | — | ($3.3m) | ($1.6m) | $0 | $0 | — | $0 | |
| Repayment Of Debt | — | — | — | — | ($3.3m) | ($1.6m) | $0 | $0 | — | $0 | |
| Issuance Of Capital Stock | — | — | — | — | $323.9m | $269.8m | $0 | $0 | — | $0 | |
| Repurchase Of Capital Stock | — | — | — | — | — | ($7.8m) | ($4.4m) | ($4.0m) | ($16k) | ($18k) | |
| Issuance of common stock in connection with the business acquisition | — | — | — | $0 | $26.8m | $77.1m | $5.9m | $0 | $0 | $0 | |
| Common Stock Issuance | — | — | — | — | $323.9m | $269.8m | $0 | $0 | — | $0 | |
| Net Common Stock Issuance | — | — | — | — | — | $262.1m | ($4.4m) | ($4.0m) | ($16k) | ($18k) | |
| Repurchases of common stock for income tax withholding | — | — | — | ($2.4m) | ($10.8m) | ($7.8m) | ($4.4m) | ($4.0m) | ($16k) | — | |
| Common Stock Payments | — | — | — | — | — | ($7.8m) | ($4.4m) | ($4.0m) | ($16k) | ($18k) | |
| Net Cash Provided by (Used in) Financing Activities | $63.8m |
$88.8m
+39.22%
|
$158.6m
+78.53%
|
$303.7m
+91.53%
|
$329.2m
+8.38%
|
$270.5m
-17.82%
|
$911k
-99.66%
|
$6.9m
+656.31%
|
$28.5m
+314.22%
|
$13.8m
-51.66%
|
|
| Net increase (decrease) in cash, cash equivalents and restricted cash | $2.5m | $50.0m | ($34.1m) | $46.8m | $373.1m | ($87.1m) | ($91.0m) | ($60.1m) | ($43.7m) | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | ($34.1m) | $46.8m | $373.1m | ($87.1m) | ($91.0m) | ($60.1m) | ($43.7m) | $119.4m | |
| Beginning Cash Position | — | — | — | — | — | $467.4m | $380.3m | $289.3m | $229.1m | $203.9m | |
| Cash, cash equivalents, and restricted cash at beginning of year | $31.6m | $81.5m | $47.4m | $94.2m | $467.4m | $380.3m | $289.3m | $229.1m | $185.4m | — | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $30k | $21k | $20k | ($319k) | ($27k) | $126k | $143k | $176k | |
| Effect of exchange rates on cash, cash equivalents and restricted cash | — | — | $30k | $21k | $20k | ($319k) | ($27k) | $126k | $143k | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $47.4m | $94.2m | $467.4m | $380.3m | $289.3m | $229.1m | $185.4m | $119.4m | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | ($319k) | ($27k) | $126k | $143k | $176k | |
| Additional Supplementary Disclosures | |||||||||||
| Additional Supplementary Disclosures | |||||||||||
| Gain (Loss) on Disposition of Business | — | — | — | — | — | — | — | — | $48.8m | — | |
| Income Tax Expense (Benefit) | — | — | $292k | $382k | ($1.9m) | ($10.4m) | $1.2m | $560k | $719k | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | $29k | — | — | |
| Operating Lease, Expense | — | — | — | $7.9m | $9.5m | $15.6m | $16.2m | — | — | — | |
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | — | — | — | $3.7m | $33.6m | $21.4m | $6.7m | $0 | $0 | — | |
| Additional Financial Items | |||||||||||
| Deconsolidation, Gain (Loss), Amount | — | — | — | — | — | $4.6m | $0 | $0 | — | — | |
| Goodwill | — | — | $1.1m | $1.1m | $22.4m | $85.8m | $85.8m | $85.8m | $82.2m | $0 | |
| Investment Income, Interest | — | — | $3.0m | $1.5m | $435k | $3.1m | $14.4m | $15.3m | $11.4m | — | |
| Realized Investment Gains (Losses) | — | — | — | — | $5k | $0 | — | — | — | — | |
| Restructuring Costs | — | — | — | — | — | — | $16.2m | $0 | $0 | — | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | $54.4m | $90.1m | $132.3m | $203.6m | $245.1m | $313.0m | $376.6m | — | |
| Non-cash lease expense, net of tenant improvement allowance | — | — | — | ($1.0m) | $2.2m | $20.1m | $2.6m | $940k | ($20k) | — | |
| Change in fair value of contingent considerations and holdbacks | — | — | — | $0 | ($534k) | ($14.2m) | ($5.9m) | $0 | $0 | — | |
| Gain on sale of business | — | — | — | — | — | — | $0 | $0 | ($48.8m) | — | |
| Other non-cash adjustments | — | — | — | — | $778k | $1.4m | $120k | $994k | $2.2m | — | |
| Other non-current assets | ($481k) | ($812k) | ($2.1m) | ($554k) | ($4.7m) | $7.3m | $1.4m | $431k | ($1.6m) | — | |
| Proceeds from sale of business | — | — | — | — | — | — | $0 | $0 | $2.5m | — | |
| Proceeds from exercise of stock options | $205k | $331k | $2.2m | $10.5m | $14.6m | $6.0m | $1.4m | $7.1m | $9.3m | — | |
| Proceeds from the issuance of liability related to sale of future revenue | — | — | — | — | — | — | $0 | $0 | $15.0m | — | |
| Proceeds from issuance under employee stock purchase plan | — | — | $2.7m | $3.4m | $4.9m | $4.0m | $3.9m | $3.8m | $4.2m | — | |
| Equity securities received as consideration for sale of business | — | — | — | — | — | — | $0 | $0 | $53.9m | — | |
| Promissory note receivable received as consideration for sale of business | — | — | — | — | — | — | $0 | $0 | $1.7m | — | |
| Conversion of convertible notes | $486k | — | — | — | $0 | $0 | $3.7m | $0 | $0 | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | $270.5m | $911k | $6.9m | $28.5m | $13.8m | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | ($232.9m) | $50.6m | ($3.1m) | ($24.8m) | ($45.2m) | |
| Change In Account Payable | — | — | — | — | — | $7.4m | ($2.5m) | ($11.8m) | $9.3m | $4.3m | |
| Change In Other Working Capital | — | — | — | — | $7.4m | $4.9m | — | — | — | — | |
| Change In Payable | — | — | — | — | — | $7.4m | ($2.5m) | ($11.8m) | $9.3m | $4.3m | |
| Change In Prepaid Assets | — | — | — | — | — | ($2.6m) | ($4.2m) | $382k | ($3.7m) | ($20.9m) | |
| Changes In Cash | — | — | — | — | — | ($86.8m) | ($91.0m) | ($60.3m) | ($43.9m) | ($84.5m) | |
| End Cash Position | — | — | — | — | — | $380.3m | $289.3m | $229.1m | $185.4m | $119.4m | |
| Financing Cash Flow | — | — | — | — | — | $270.5m |
$911k
-99.66%
|
$6.9m
+656.31%
|
$28.5m
+314.22%
|
$13.8m
-51.66%
|
|
| Free Cash Flow | — | — | — | — | — | ($226.2m) | ($170.3m) | ($69.2m) | ($75.6m) | ($93.2m) | |
| Gain Loss On Sale Of Business | — | — | — | — | — | ($4.6m) | $0 | $0 | ($48.8m) | $0 | |
| Gain Loss On Sale Of PPE | — | — | — | — | $2k | $0 | — | — | — | — | |
| Investing Cash Flow | — | — | — | — | — | ($232.9m) | $50.6m | ($3.1m) | ($24.8m) | ($45.2m) | |
| Net Business Purchase And Sale | — | — | — | — | — | ($13.9m) | $0 | $0 | $2.5m | ($5.0m) | |
| Net PPE Purchase And Sale | — | — | — | — | — | ($101.9m) | ($27.8m) | ($5.1m) | ($28.0m) | ($40.1m) | |
| Operating Gains Losses | — | — | — | — | ($3k) | ($4.6m) | — | — | ($48.8m) | ($48.8m) | |
| Other Non Cash Items | — | — | — | — | — | $7.3m | ($3.2m) | $1.9m | $2.2m | — | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | $10.0m | $5.3m | $10.9m | $13.6m | $13.8m | |
| Provisionand Write Offof Assets | — | — | — | — | $40k | ($11k) | — | — | — | — | |
| Purchase Of Business | — | — | — | — | ($483k) | ($13.9m) | $0 | $0 | — | $0 | |
| Purchase Of PPE | — | — | — | — | — | ($101.9m) | ($27.8m) | ($5.1m) | ($28.0m) | ($40.2m) | |
| Stock Based Compensation | — | — | — | — | — | $79.7m | $30.3m | $50.9m | $64.5m | $66.5m | |
| Net Investment Purchase And Sale | — | — | — | — | — | ($117.2m) | $78.4m | $2.0m | $742k | ($89k) | |
| Purchase Of Investment | — | — | — | — | — | ($217.6m) | ($76.3m) | ($51.9m) | ($49.4m) | ($59.6m) | |
| Sale Of Investment | — | — | — | — | — | $100.5m | $154.7m | $53.9m | $50.1m | $59.5m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | ($87.1m) | ($91.0m) | ($60.1m) | ($43.7m) | — | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | $779k | $438k | $167k | $9k | $0 | $0 | — | — | |
| Income Taxes Paid, Net | $6k | $179k | $291k | $172k | $101k | $246k | $420k | $344k | $683k | — |